NCT07286331 is a Phase 3 clinical trial of GSK5733584 in Neoplasms, Endometrial, sponsored by GlaxoSmithKline.

Who is sponsoring NCT07286331?

NCT07286331 is sponsored by GlaxoSmithKline.

What drugs are being tested in NCT07286331?

Interventions in NCT07286331: GSK5733584, Paclitaxel, Doxorubicin.

What condition does NCT07286331 study?

NCT07286331 studies Neoplasms, Endometrial.

Is NCT07286331 still recruiting?

NCT07286331 is currently not yet recruiting. Last updated 11 March 2026.

Last reviewed 2026-03-11 · How we verify

NCT07286331

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-Endometrial01)

Not yet recruiting Phase 3 Last updated 11 March 2026

What this trial tests

Phase 3 trial testing GSK5733584 in Neoplasms, Endometrial in 600 participants. Not yet recruiting.

Timeline

9 June 2026

Primary endpoint
29 February 2028

30 May 2029

Quick facts

Lead sponsor	GlaxoSmithKline
Phase	Phase 3
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	600
Start date	9 June 2026
Primary completion	29 February 2028
Estimated completion	30 May 2029

Drugs / interventions tested

GSK5733584 — full drug profile →
Paclitaxel — full drug profile →
Doxorubicin (doxorubicin) — full drug profile →

Conditions studied

Neoplasms, Endometrial — all drugs for Neoplasms, Endometrial →

Sponsor

GlaxoSmithKline — full company profile →

Who can join

18 and older, female only, with Neoplasms, Endometrial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study specifically aims to evaluate how well GSK5733584 works in treating Endometrial Cancer (EC) compared to standard of care. The study also assesses whether GSK5733584 is safe and tolerated well by participants in comparison to standard of care and will help provide a better understanding of the main side effects of the drugs

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of GSK5733584

Trials testing the same drug.

NCT07286266 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEH · Phase 3 · not yet recruiting
NCT06796907 — A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
NCT06431594 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Part · Phase 1 · recruiting

Other recruiting trials for Neoplasms, Endometrial

Currently open trials in the same condition.

NCT07108270 — A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recur · Phase 2 · recruiting

Other GlaxoSmithKline trials

Trials by the same sponsor.

NCT07569081 — A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflam · Phase 2, PHASE3 · not yet recruiting
NCT07406347 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose · Phase 1 · not yet recruiting
NCT07286266 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEH · Phase 3 · not yet recruiting
NCT07406334 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months · Phase 1 · not yet recruiting
NCT07406360 — A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07286331 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by GlaxoSmithKline
Last refreshed: 11 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07286331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing